kw.\*:("Agonista parcial")
Results 1 to 25 of 1172
Selection :
Thiazolidinediones Are Partial Agonists for the Glucocorticoid ReceptorMATTHEWS, L; BERRY, A; TERSIGNI, M et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 1, pp 75-86, issn 0013-7227, 12 p.Article
U-80816 : a novel partial muscarinic agonistSETHY, V. H; FRANCIS, J. W; PIERCEY, M. F et al.Drug development research. 1991, Vol 24, Num 1, pp 53-66, issn 0272-4391Article
The Antagonists But Not Partial Agonists of Glucocorticoid Receptor Ligands Show Substantial Side Effect DissociationXIAO HU; SARAH DU; HEGDE, Shridhar G et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 8, pp 3123-3134, issn 0013-7227, 12 p.Article
A Perioperative Smoking Cessation Intervention with Varenicline: A Double-blind, Randomized, Placebo-controlled TrialWONG, Jean; ABRISHAMI, Amir; YILIANG YANG et al.Anesthesiology (Philadelphia). 2012, Vol 117, Num 4, pp 755-764, issn 0003-3022, 10 p.Article
Partial dopamine agonists in the treatment of psychosisTAMMINGA, C. A.Journal of neural transmission. 2002, Vol 109, Num 3, pp 411-420, issn 0300-9564Article
A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypesSAKAMOTO, Junichi; KIMURA, Hiroyuki; MORIYAMA, Shinji et al.European journal of pharmacology. 2004, Vol 495, Num 1, pp 17-26, issn 0014-2999, 10 p.Article
Non-prostanoid prostacyclin mimetics. VI: Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified β-to the oxazole ringMEANWELL, N. A; ROSENFELD, M. J; ZAVOICO, G. B et al.Drug design and discovery (Print). 1994, Vol 11, Num 1, pp 73-89, issn 1055-9612Article
Review article: tegaserod: the global experienceCHEY, W. D.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 15-19, issn 0953-0673, 5 p.Article
The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonistGRIFFON, N; PILON, C; SCHWARTZ, J.-C et al.European journal of pharmacology. 1995, Vol 282, Num 1-3, pp R3-R4, issn 0014-2999Article
Sentiment Analysis to Determine the Impact of Online Messages on Smokers' Choices to Use VareniclineCOBB, Nathan K; MAYS, Darren; GRAHAM, Amanda L et al.Journal of the National Cancer Institute. Monographs. 2013, Vol 47, pp 224-230, issn 1052-6773, 7 p.Article
Effects of Varenicline on Smoking Cue-Triggered Neural and Craving ResponsesFRANKLIN, Teresa; ZE WANG; SUH, Jesse J et al.Archives of general psychiatry. 2011, Vol 68, Num 5, pp 516-526, issn 0003-990X, 11 p.Article
Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia : Results of two Randomized Controlled TrialsVAKIL, Nimish; LAINE, Loren; TALLEY, Nicholas J et al.The American journal of gastroenterology. 2008, Vol 103, Num 8, pp 1906-1919, issn 0002-9270, 14 p.Article
Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors : use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classesSHARIF, N. A; WILLIAMS, G. W; DESANTIS, L. M et al.Neurochemical research. 1995, Vol 20, Num 6, pp 669-674, issn 0364-3190Article
Partial agonist properties of cystisine on neuronal nicotinic receptors containing the β2 subunitPAPKE, R. L; HEINEMANN, S. F.Molecular pharmacology. 1994, Vol 45, Num 1, pp 142-149, issn 0026-895XArticle
Partial agonists, full agonists, antagonists : dilemmas of definitionHOYER, D; BODDEKE, H. W. G. M.Trends in pharmacological sciences (Regular ed.). 1993, Vol 14, Num 7, pp 270-275, issn 0165-6147Article
Estimation of partial agonist affinity by interaction with a full agonist : a direct operational model-fitting approachLEFF, P; DOUGALL, I. G; HARPER, D et al.British journal of pharmacology. 1993, Vol 110, Num 1, pp 239-244, issn 0007-1188Article
Dose-proportionality of eltoprazine : pharmacokinetics of single oral doses in healthy subjectsDE VRIES, M. H; DE KONING, P; FLOOT, H. L et al.European journal of clinical pharmacology. 1991, Vol 41, Num 5, pp 485-488, issn 0031-6970Article
Vilazodone: Clinical Basis for the US Food and Drug Administration's Approval of a New AntidepressantLAUGHREN, Thomas P; GOBBURU, Jogarao; LEVIN, Robert L et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 9, pp 1166-1173, issn 0160-6689, 8 p.Article
Identification and optimization of novel partial agonists of Neuromedin B receptor using parallel synthesisSHUTTLEWORTH, Stephen J; LIZARZABURU, Mike E; CHAI, Anne et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 12, pp 3037-3042, issn 0960-894X, 6 p.Article
Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia : A study group reportDELINI-STULA, A; BERDAH-TORDJMAN, D.Journal of psychiatric research. 1996, Vol 30, Num 4, pp 239-250, issn 0022-3956Article
Antidepressant activity of buspirone in anxietyALLMANN, B. J. C; DOMANTAY, A; SCHOEMAN, H. S et al.Current therapeutic research. 1992, Vol 52, Num 3, pp 406-411, issn 0011-393XArticle
Multiple Mechanisms Underlying the Long Duration of Action of Thienorphine, A Novel Partial Opioid Agonist for the Treatment of AddictionGANG YU; LI, Shu-Hui; CUI, Meng-Xun et al.CNS neuroscience & therapeutics (Print). 2014, Vol 20, Num 3, pp 282-288, issn 1755-5930, 7 p.Article
Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patientsVAN BERCKEL, B. N. M; HIJMAN, R; VAN DER LINDEN, J. A et al.Biological psychiatry (1969). 1996, Vol 40, Num 12, pp 1298-1300, issn 0006-3223Conference Paper
Oxadiazolylimidazobendiazepines as novel partial agonists with the benzodiazepine receptor : a QSAR analysisSHARMA, R. C; SINGH, P; OJHA, T. N et al.Research communications in chemical pathology and pharmacology. 1993, Vol 80, Num 3, pp 357-362, issn 0034-5164Article
Can nicotine self-inhibition account for its low efficacy at the nicotinic acetylcholine receptor from Torpedo ?TONNER, P. H; WOOD, S. C; MILLER, K. W et al.Molecular pharmacology. 1992, Vol 42, Num 5, pp 890-897, issn 0026-895XArticle